In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Matthew Stober, Chief Executive Officer at Abzena.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Matt, covering:

• How the failure of a big pharma R&D portfolio led to the creation of a CDMO business and a pipeline-ready facility

Matt joined Abzena from his role at Istari Oncology where he served as President and Chief Executive Officer for two years. He has over 30 years of experience at large, multinational pharmaceutical organizations, in manufacturing operational roles.

Matt has previously held senior executive positions at Novartis Vaccines, Smith and Nephew and Hospira where he served as Global Head of Operations, President of Operations, and Senior Vice President of Operations respectively.

His deep and extensive operational experience has been consolidated from positions at companies including GlaxoSmithKline, Merck and Pfizer. Matt holds various Board positions including current appointments at X-Vax Technology, Istari Oncology and Castlevax. He holds a B.S. in chemical engineering from Villanova University, PA, USA.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.